Clinical translation of stem cell therapies requires clear definition and characterization of the cell populations, especially in a biologically diverse group of non-human mammalian species.
Clinical translation of stem cell therapies requires clear definition and characterization of the cell populations, especially in a biologically diverse group of non-human mammalian species.
The process of metastasis, in which cancer cells migrate to distant organs from the primary tumor region, is the key pathological event responsible for 90% of all of the cancer-related deaths. The critical early steps of the metastatic cascade of events, namely...
Submit your abstract for NANO2018 conference at City University of Hong Kong by 28 February 2018.
Synthetic cells that function as autonomous systems for producing an anti-cancer protein inside the body are developed.
A special issue on the proteome associated with these extracellular environment constituents of different organisms ranging from microorganisms to plants and humans.
Modifications to chromatin are associated with the development of metabolic diseases, including Type 2 diabetes and obesity. There is evidence that these chromatin modifications can lead to long-term disease risk and increased disease risk for offspring.
Bioinspired, biohybrid device design and fabrication strategy for investigating the ability of therapeutics to cross the blood brain barrier.
Cell printing using this new electro-hydrodynamic technique allows the creation of cell structures with multiple layers and a high cell viability.
Advanced Healthcare Materials Special issue on “Microphysiological Analytic Platforms (MAPs): Precision Organs on Chip” edited by Luke P. Lee.
A novel reactive oxygen species (ROS)-promoted nanomedicine platform can effectively inhibit tumor growth, reduce side effects experienced in common anticancer drugs, while promote on-target uptake.